Research on Diabetes Integrated Therapy (D.I.T)
Type 2 diabetes currently affects
over 537 million people worldwide (approximately 9% of the population)
In Taiwan, the rate is as high as 13%, making it one of the greatest health threats. Recent international medical research has confirmed that "Hyperinsulinemia" is the true root cause of diabetes and obesity.

However, traditional medicine has long overlooked insulin monitoring and regulation, resulting in patients continuing medication without truly addressing the underlying cause.
8.6%

China / 1.408 billion / 120 million

10.9%

United States / 341 million / 37 million

13.0%

Taiwan / 23 million / 3 million

Root Cause Revealed: The Origin of Diabetes Is
“Hyperinsulinemia”
Modern lifestyles are characterized by high sugar, high fat, and high-GI diets, leading to chronic overproduction of insulin and metabolic imbalance. Insulin resistance and hyperinsulinemia not only contribute to diabetes and obesity, but are also closely associated with cardiovascular disease, kidney disease, cancer, and neurodegenerative disorders. Under this chain effect, globally each year:
20 million

Over 20 million people die from stroke and myocardial infarction

10 million

Approximately 10 million people die from cancer

5 million

5 million people die from diabetes-related complications

 
Diabetes Integrated Therapy (D.I.T) | A New Standard in Metabolic Medicine
Glucose-Blocking Biotechnology
+
Insulin Monitoring
+
Medical Treatment
Based on years of research, Green World Biotechnology has developed Diabetes Integrated Therapy (D.I.T), an innovative treatment approach that starts from the root cause and combines glucose-blocking biotechnology, insulin monitoring, and medical treatment. Its core objective is to simultaneously improve insulin resistance and hyperinsulinemia, truly helping patients with type 2 diabetes restore metabolic balance.
01

Core Principle: A Treatment Approach Targeting the Root Cause

Glucose-Blocking Biotechnology: The First Step to Reducing Insulin Burden
Glucose-blocking technology can prevent approximately two-thirds of sugar from entering the body, significantly reducing Sugar-input. This prevents post-meal blood sugar spikes and allows insulin secretion to rest. This process effectively improves:

・ insulin resistance
・ hyperinsulinemia
・ body fat accumulation and obesity risk

Equivalent to treating the root cause and gradually restoring normal metabolic function.
Medication Therapy and Insulin Monitoring: Amplified Effectiveness
Once insulin burden is reduced, medications can function more effectively, accelerating metabolic improvement. Through insulin level and C-peptide testing to monitor patient conditions, treatment strategies can be dynamically adjusted to enhance outcomes, including:

・ lowering blood glucose
・ improving insulin resistance
・ reducing insulin dependence
02

Win-Win Treatment Model: Glucose Blocking × Medication = 1 + 1 > 2

Glucose-Blocking Reduces Insulin, Easing Metabolic Burden and Enhancing Drug Efficacy
Glucose-blocking technology lowers insulin levels → reduces metabolic stress → allows medications to work more effectively. This creates a “dual-improvement” therapeutic effect, including:

・ faster improvement in insulin resistance
・ significantly improved blood sugar stability
・ reduced risk of complications

This model breaks through the limitations of medication-only approaches and represents a true root-cause-driven solution in metabolic medicine.
Diabetes Integrated Therapy
Diabetes Integrated Therapy, D.I.T
03

Clinical Applications and Treatment Outcomes

Clinical studies show that patients with type 2 diabetes receiving D.I.T. as an adjunct therapy have demonstrated significant improvements across multiple indicators:
D.I.T is also applicable to obesity prevention and metabolic syndrome management, helping patients break free from long-term medication dependence and truly regain a healthy lifestyle.
Significant reduction in insulin levels
Improved blood sugar stability
Improvement in body weight and body fat ratio
Reduced long-term recurrence rate
04

Treatment Vision: Diabetes Has the Potential to Be Cured

Diabetes Integrated Therapy (DIT) Model
Significantly reduces Sugar-input and lowers blood insulin levels
Type 2 diabetes is not irreversible—
through the right treatment, it has the potential to be cured.
D.I.T has been clinically proven: by focusing on three key factors—“reducing Sugar-input,” “restoring insulin balance,” and “dual metabolic improvement”—this therapy not only alleviates symptoms, but fundamentally reshapes the metabolic environment and reactivates the body's natural health cycle.